Nektar Therapeutics Inc. (NKTR)
NASDAQ · Healthcare
Nektar Therapeutics Inc. Operating Income 2009–2025
Nektar Therapeutics Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Nektar Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -39.1 M, a 12.31% decrease year-over-year.
- Nektar Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -151.5 M, a 7.86% decrease year-over-year.
- Nektar Therapeutics Inc. annual operating income for 2025 was -140.1 M, a 33.18% increase from 2024.
- Nektar Therapeutics Inc. annual operating income for 2024 was -105.2 M, a 60.10% decrease from 2023.
- Nektar Therapeutics Inc. annual operating income for 2023 was -263.7 M, a 29.90% decrease from 2022.
- Nektar Therapeutics Inc. annual operating income for 2022 was -376.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Nektar Therapeutics Inc. Operating Income — FAQ
Nektar Therapeutics Inc. (NKTR) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Nektar Therapeutics Inc.'s operating income?
Nektar Therapeutics Inc. (NKTR) reported operating income of -$140M for fiscal 2025.
Where can I see NKTR's operating income history?
The chart and table above show Nektar Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.